1. A review of clinical trials of human papillomavirus prophylactic vaccines;Schiller;Vaccine,2012
2. World Health Organization. Weekly epidemiological record. Weekly Meeting of the Strategic Advisory Group of Experts on Immunization, October 2019: conclusions and recommendations. 2019. No 47(94): p. 541-560.
3. Strategic Advisory Group of Experts (SAGE) on Immunization. Working Group on potential contribution of Human Papillomavirus (HPV) vaccines and immunization towards cervical cancer elimination. Background Document and Report to SAGE. https://www.who.int/immunization/sage/meetings/2019/october/1_HPV_SAGE2019WG_for_SAGE.pdf, 2019.
4. PATH, Global HPV Vaccine Introduction Overview. Projected and current national introductions, demonstration/pilot projects, gender-neutral vaccination programs, and global HPV vaccine introduction maps (2006-2023). https://path.azureedge.net/media/documents/Global_HPV_Vaccine_Intro_Overview_Slides_webversion_2020May.pdf, 2020.
5. IPVS statement on “Temporary HPV vaccine shortage: Implications globally to achieve equity”;Garland;Papillomavirus Res,2020